• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CBER

Parachute over a desert
Biotech

BioNTech founders to pioneer new company—Chutes & Ladders

BioNTech founders will depart to pioneer new company. OSE makes interim CEO permanent. Ipsen adds former Alltrna CEO as North America leader.
Darren Incorvaia , Zoey Becker , Will Maddox Mar 13, 2026 8:30am
Prasad

CBER Director Vinay Prasad to depart FDA—again

Mar 6, 2026 5:30pm
Albert Bourla Pfizer CEO Bourla
Favicon Fierce Pharma

Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad

Mar 3, 2026 4:58pm
gene editing edit gene CRISPR

FDA illuminates new approval pathway for bespoke gene therapies

Feb 23, 2026 11:30am
The White House

Trump met with Makary before FDA’s Moderna walkback: report

Feb 19, 2026 11:30am
Moderna

Moderna hit with FDA refusal-to-file letter for mRNA flu shot

Feb 10, 2026 7:45pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings